Document is current
Any future updates will be listed below
-
Authors
Maillard, Nicolas
El Karoui, Khalil
Mercer, Alex
Hunt, Barnaby https://orcid.org/0000-0001-5420-279X
Carroll, Kevin J.
-
Funding
Funding for this research was provided by:
CSL Vifor
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 7 October 2025
First Online: 12 November 2025
Declarations
:
: Nicolas Maillard has received consulting and travel fees from CSL Vifor and consulting fees from Alexion. Khalil El Karoui has received consulting and travel fees from CSL Vifor and Novartis and consulting fees from Alexion. Alex Mercer is a consultant to Travere Therapeutics Inc. through contract with JAMCO Pharma Consulting AB. Barnaby Hunt is an employee of Ossian Health Economics and Communications, which received consulting fees from CSL Vifor to support preparation of the analysis. Kevin J Carroll is a director of KJC Statistics Ireland Ltd., which has received consulting fees from Travere Therapeutics Inc and CSL Vifor.
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
